Louise M. Nitze
Soborg, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Letter: Non-Invasive Tests After Semaglutide in MASH as Disease-Activity Readouts Rather Than Response Biomarkers. Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: July 22, 2026
Exploration of Multiple Non-Invasive Tests for Assessing Response to Treatment in a Semaglutide Phase 2b Trial in Patients with MASH.
Journal: Alimentary pharmacology & therapeutics
Published: March 03, 2025
Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis.
Journal: Nature medicine
Published: October 08, 2024
Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis.
Journal: Hepatology communications
Published: October 13, 2023
Prognostic utility of Fibrosis-4 Index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and/or type 2 diabetes: a longitudinal cohort study.
Journal: The Lancet regional health. Europe
Published: July 14, 2023
Collagen induces maturation of human monocyte-derived dendritic cells by signaling through osteoclast-associated receptor.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 01, 2015
Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer.
Journal: Breast cancer research and treatment
Published: July 23, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026